2 Biotech Stocks That Surged More Than 100% in September

This post was originally published on this site

Increasing demand for biotech applications and solutions across various end-user industries such as food, agriculture, and healthcare, plus growing demand for synthetic biology are expected to help boost the industry’s growth. According to a Research and Market’s report, the global biotechnology market is expected to grow at a CAGR of 8.57% over the next five years.

Amid this backdrop, quality biotech stocks Leap Therapeutics, Inc. (LPTX) and Corvus Pharmaceuticals, Inc. (CRVS), which have surged more than 100% last month, could be good additions to your portfolio.

Continue reading on StockNews